October 19 - 20, 2008

Cambridge-Boston, Mass



Leading the Way for the Future of ALS Research

An open discussion between ALS patients and ALS researchers hosted by the world's leading

translational ALS research center. The ALS TDI Leadership Summit is a two-day event aimed at providing

a forum for the exploration of the past, present and future of research towards an effective

treatment for amyotrophic lateral sclerosis.







Sunday, October 19, 2008

Lab Tours and Open House

ALS TDI, Cambridge, MA

(Directions and Map)



The lab doors at ALS TDI are always open to you and during the Leadership Summit, we host a series

of special lab tours which are designed to explain the research and development process from the ground up.

This is your chance to go inside the world's only nonprofit biotech lab solely focused on finding a cure for ALS.



Lab Tour
Time

Lab Tour I 10:00am (register)
Lab Tour II 1:00pm (register)
Lab Tour III 4:00pm (register)



About the Lab Tour:

Seeing is knowing that there are dedicated researchers working on stopping ALS - lots of them!



Limited to 30 persons, each tour will begin with an introduction to drug discovery and our research

pipeline. Several of our science team members will participate in this round-robin presentation, held in the

conference room at ALS TDI in Cambridge. You will be introduced to preclinical research, cell and molecular

biology, genotyping, among other tools used to advance therapeutics for ALS. After the short presentation

each group will be invited to take a walk thru of our laboratory space and ask questions.







Monday, October 20th

Research Symposium

Holiday Inn at Beacon Hill - Boston, MA



The Research Symposium brings together scientists and clinicians from across the spectrum of ALS research.

It is central to the mission of ALS TDI to foster collaboration and openness in ALS research, and we invite

you to attend and be a part of this important event. Some presenters collaborate with ALS TDI,
while others are internal researchers.

After each speaker a period of Q&A will follow.

We provide an open platform for attendees to ask questions during this time.

Portions of the Research Symposium may be taped or photographed.



8:00am Morning Coffee Break

8:30am
TBA

TBA

8:40am
Sean Scott

President

ALS TDI

Cambridge, MA
Click for Bio
Our Plan, our Progress, your Lab

8:50am
Sharon Hesterlee, Ph.D.

VP, Translational Research

Muscular Dystrophy Association

Tucson, AZ

Continuing the World's Largest Attack on ALS

9:15am
Mike Strong, Ph.D..

Chief of Neurology

London Health Sciences Centre

London, Ontario, Canada
Click for Bio
TBA

10:00am
Jean-Pierre Julien, Ph.D.

Professor

Laval University

Quebec, QC, Canada
Click for Bio
TBA

10:45am
G. Thomas Caltagirone, Ph.D.

President & CEO

Aptagen, LLC

Jacobus, PA
Click for Bio
Developing an Aptamer Library for ALS

11:30pm
Lunch Break

12:15pm
Speaker TBA


1:00pm
Troy Jurgenson

Co-Founder

Speak Up ALS

Corona del Mar, CA

A Comprehensive Approach to Communication Systems for ALS Patients and their Families

1:45pm Steve Perrin, Ph.D.

Chief Scientific Officer

ALS TDI

Cambridge, MA
Click for Bio
The Genomic and Proteomic Approach to ALS Research
2:30pm John McCarty, Ph.D.
Treatment Investigator

ALS TDI

Cambridge, MA
Click for Bio
Information Resources for ALS Patients and Researchers
3:15pm Stan Appel, M.D.
Co-Founder & Co-Director

Methodist Neurological Institute

Houston, TX
Click for Bio
The Role of Inflammation in ALS
4:00pm ALS TDI Leadership Awards

Click here to submit your nomination




CLICK HERE TO REGISTER

.

Schedule is subject to changes. Check back often